Packaging system and methods of alerting a practitioner

Patent metadata

Field	Value
Publication number	US-10702452-B2
Application number	US-201514591512-A
Country	US
Kind code	B2
Filing date	Jan 7, 2015
Priority date	Jun 13, 2007
Publication date	Jul 7, 2020
Grant date	Jul 7, 2020

Abstract

A packaging system includes a container having a closed end an open end, a longitudinal axis running through the closed end and the open end, and an outer surface. A closure assembly fitted to the open end of the container has an access port. The system also includes a detachable cap disposed over the access port, and a label disposed about the container, characterized in that the label has a first region angled relative to the longitudinal axis, which first region consists essentially of a name of an injectable drug product, and a second region angled relative to the longitudinal axis, which second region consists essentially of a concentration of the injectable drug product, whereby the said first and second regions are angled such as to lie in planes that make non-zero as well as non-right angles with the longitudinal axis.

First claim

What is claimed is:

1. A packaging system comprising:
a container having a closed end, an open end, a longitudinal axis running through the closed end and the open end, and an outer surface;
a closure assembly fitted to the open end of the container and having an access port;
a detachable cap disposed over the access port; and
a tubular label disposed about the perimeter of the container and extending from a lower edge aligned with the closed end of the container to an upper edge at the cap, wherein
the label has a first region having an angle relative to the longitudinal axis between 20 and 80 degrees, the first region consisting essentially of a name of an injectable drug product, and
a second region having an angle relative to the longitudinal axis between 20 and 80 degrees, the second region consisting essentially of a concentration of the injectable drug product, whereby the said first and second regions are angled such as to lie in planes that make non-zero as well as non-right angles with the longitudinal axis.

2. The packaging system of claim 1 , wherein the first region of the label has a background of a color that contrasts with a remainder of the label.

3. The packaging system of claim 2 , wherein the first and second regions of the label have a background of a color that contrasts with the remainder of the label.

4. The packaging system of claim 1 , wherein the closure assembly includes a valve disposed over the open end and a crimp ring with a first end disposed over a portion of the valve to define the access port and a second end.

5. The packaging system of claim 4 , wherein:
the container comprises a cylindrical glass vial including a wall defining the closed end and open end, the wall having an outer surface, an inner surface defining a receptacle, and a flange-like rim disposed about the open end; and
the second end of the crimp ring is disposed over a portion of the flange-like rim.

6. The packaging system of claim 4 , wherein the crimp ring is of a color that contrasts with one or more regions of the label.

7. The packaging system of claim 4 , wherein the cap has a top surface and comprises a warning message defined on the top surface.

8. A system for labeling a drug container, the system comprising:
a drug container containing an injectable drug, the drug container comprising:
a closed end;
an open end;
a longitudinal axis running through the closed end and the open end; and
an outer surface; and

a tubular label disposed about the perimeter of the drug container and extending from a lower edge aligned with the closed end of the drug container to an upper edge at a cap, the label comprising:
a background section including characters perpendicular to and/or parallel with the longitudinal axis;
a drug name section visually set off from the background section, the drug name section including characters conveying a name of the injectable drug, the drug name section and the characters conveying the name of the injectable drug angled relative to the longitudinal axis of the drug container such that the characters conveying the name of the injectable drug are neither perpendicular to nor parallel with the longitudinal axis;
a concentration section visually set off from the background section, the concentration section including characters conveying a concentration of the injectable drug, the concentration section and the characters conveying the concentration of the injectable drug also angled relative to the longitudinal axis of the drug container,

wherein the drug name section and the concentration section are each angled so as to lie in planes that make non-zero and non-right angles with the longitudinal axis, and
wherein the drug name section, the concentration section, or both are set off from the background section by one or more of: (i) a color of the drug name section; (ii) a color of the characters conveying the name of the injectable drug; (iii) a font type of the characters conveying the name of the injectable drug; and/or (iv) a font size of the characters conveying the name of the injectable drug.

9. The system of claim 8 , wherein the drug name section is set off from the background section by the color of the drug name section.

10. The system of claim 8 , wherein the drug container further comprises a closure assembly including a valve disposed over the open end and a crimp ring with a first end disposed over a portion of the valve to define an access port and a second end.

11. The system of claim 10 , wherein:
the drug container comprises a cylindrical glass vial including a wall defining the closed end and open end, the wall having an outer surface, an inner surface defining a receptacle, and a flange-like rim disposed about the open end; and
the second end of the crimp ring is disposed over a portion of the flange-like rim.

12. The system of claim 10 , wherein the crimp ring is of a color that contrasts with the drug name section, the concentration section, or both the drug name section and the concentration section.

13. The system of claim 10 , further comprising a cap having a top surface and a warning message defined on the top surface.

14. The system of claim 8 , wherein the label is perforated at a boundary between a first portion and a second portion and the second portion extending at least between the boundary and a cap disposed over an access port defined by a closure assembly.

15. The system of claim 14 , wherein the first portion is circumferentially adhered to the outer surface and includes the drug name section and the concentration section, and the second portion is configured to be removed with the cap.

Assignees

• Baxter Int
• Baxter Healthcare Sa

Inventors

• Mcclain Kimberly A
• Baklycki Michael
• Mcdevitt Thomas D

Classifications

• B65D23/085 Primary

  and glued or otherwise sealed to the bottle (B65D23/0857, B65D23/0864, B65D23/0871 take precedence) · CPC title

• B65D51/002

  Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means · CPC title

• B65D51/245

  provided with decoration, information or contents indicating devices, labels (B65D81/366 takes precedence) · CPC title

• B65D55/0818

  Destructible or permanently removable bands, e.g. adhesive · CPC title

• A61J1/18 Primary

  Arrangements for indicating condition of container contents, e.g. sterile condition · CPC title